{"anticipatedPostingDate":"2029-06","denomUnitsSelected":"Participants","description":"DOR is defined as the time of initial response until documented tumor progression. Response was assessed by the and is defined as an increase in symptoms or \\>25% decline in hematologic parameters related to disease, based on the judgement of the principal investigator. ≥50% increase in sum of products of perpendicular diameters of evaluable (\\> 2cm) lymphadenopathy or appearance of new evaluable lymph nodes \\> 2 cm short axis.","reportingStatus":"NOT_POSTED","timeFrame":"28-42 days after day 1 of the last treatment.","title":"Duration of Response (DOR)","type":"SECONDARY"}